Event: on December 28, the Ministry of industry and information technology issued the “14th five year plan” for the development of medical equipment industry, put forward the overall goal of the development of medical equipment industry in 2025 and the long-term goal in 2035, and put forward the “7556” promotion idea to ensure the realization of the goal, that is, around 7 key areas, deploy 5 key tasks, implement 5 special actions and take 6 safeguard measures.
The plan will have a far-reaching impact on the whole industrial chain of medical device and equipment industry. Over the past decade, China’s medical device industry has developed rapidly, with a market scale of 840 billion yuan in 2020, and has become an important production base of global epidemic prevention materials in the process of epidemic resistance. However, the trend of global industrial chain adjustment has also exposed the problems of large but not strong and low value chain of China’s medical device industry. Therefore, this plan focuses on industrial high-end upgrading In terms of security and stability of the supply chain, making up for weaknesses in core technologies, cross-border integration, promotion and application of innovative products, the goals by 2025 are: the industrial foundation of medical equipment will be advanced, the level of industrial chain modernization will be significantly improved, the mainstream medical equipment will basically achieve effective supply, and the performance and quality of high-end medical equipment products will be significantly improved, Initially form a comprehensive support capacity for public health and medical health needs. By 2035, the R & D, manufacturing and application of medical equipment will be upgraded to the world advanced level. We believe that this plan is the first Five-Year Plan after the trade war and epidemic situation, which will have a far-reaching impact on the innovation and upgrading of the whole industrial chain of medical devices.
Put forward the promotion idea of “7556”, and the domestic equipment leaders are expected to benefit. The plan focuses on seven key areas, deploys five key tasks, implements five special actions and takes six safeguard measures to promote the realization of the development goal of the medical equipment industry. Among them, 7 key areas are diagnosis and testing equipment, treatment equipment, monitoring and life support equipment, TCM diagnosis and treatment equipment, maternal and child health equipment, health care and rehabilitation equipment and active implant intervention equipment, which basically covers the needs of the whole population for all-round life-cycle medical and health service equipment from prevention, diagnosis, treatment to health, care and maintenance. With the gradual realization of the target at that time, the position of domestic device enterprises in the global industrial division and value chain will be greatly improved. It is expected that 6-8 enterprises will rank among the top 50 in the global medical device industry in 2025. We expect the threshold income of the top 50 in the world in 2025 to be about 15 billion yuan, while the current sixth place in China Jiangsu Yuyue Medical Equipment And Supply Co.Ltd(002223) the income consistency in 2021 is expected to be 7 billion yuan. According to the plan, The leading technology level of domestic devices, industrial chain security, cross-border integration ability, import substitution ability and internationalization ability are expected to be gradually improved.
It is recommended to focus on the leading enterprises benefiting from key areas, and recommend Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) , Jiangsu Yuyue Medical Equipment And Supply Co.Ltd(002223) , Nanjing Vishee Medical Technology Co.Ltd(688580) , minimally invasive Siasun Robot&Automation Co.Ltd(300024) , Qiming medical, etc
1) Diagnostic test equipment: Advanced Cell Analysis ( Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) ), new generation imaging (United imaging medical), POCT ( Guangzhou Wondfo Biotech Co.Ltd(300482) )
2) Treatment equipment: radiotherapy ( Shinva Medical Instrument Co.Ltd(600587) , United imaging medical), surgery Siasun Robot&Automation Co.Ltd(300024) (minimally invasive Siasun Robot&Automation Co.Ltd(300024) , Tinavi Medical Technologies Co.Ltd(688277) )
3) Monitoring and life support equipment: new monitoring equipment, ventilator ( Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) ), dialysis equipment ( Jiangxi Sanxin Medtec Co.Ltd(300453) , Weigao)
4) TCM diagnosis and treatment equipment: Acupuncture and rehabilitation ( Jiangsu Yuyue Medical Equipment And Supply Co.Ltd(002223) )
5) Maternal and child health equipment: health care during pregnancy and childbirth ( Nanjing Vishee Medical Technology Co.Ltd(688580) )
6) Health care and rehabilitation equipment: rehabilitation Siasun Robot&Automation Co.Ltd(300024) , electrotherapy, magnetic therapy ( Nanjing Vishee Medical Technology Co.Ltd(688580) ), phototherapy ( Shenzhen Lifotronic Technology Co.Ltd(688389) ), rehabilitation aids ( Xiangyumedicalco.Ltd(688626) )
7) Active implant interventional devices: pacemaker (minimally invasive rhythm, Lepu Medical Technology (Beijing) Co.Ltd(300003) ), heart failure treatment intervention (Qiming medical), nerve stimulation (Pinchi medical), bioactive compliance materials ( Yantai Zhenghai Bio-Tech Co.Ltd(300653) )
Risk tips: policy cost control risk and R & D failure risk.
